Literature DB >> 15206167

Sex steroid receptors, secondary bile acids and colorectal cancer. A possible mechanism of interaction.

L Berta1, C Fronticelli Baldelli, A Fazzari, E Radice, A Bargoni, R Frairia, A Gaetini.   

Abstract

AIM: The aim of the work was to study in colon-rectum cancer mucosae the binding charateristics, as sex steroid receptors.
METHODS: Specific androgen (AR), estrogen (ER) and progesterone (PgR) receptors were measured in the tissue samples of 35 patients (15 males, 20 females) undergoing colectomy or coloproctectomy for adenocarcinoma. The characteristics of androgen receptor (AR, DHT-R: dihydrotestosterone receptor) were also investigated using competitive activity of cyproterone acetate, cortisol, aldosterone and steroid-like substances such as deoxycholic and lithocholic acid, present in the milieu of the considered organ. Binding assays and competition tests were conducted using a charcoal dextran method.
RESULTS: When present (50%), ER and PgR receptors showed very low levels and no difference was noted between cancerous and the surrounding healthy mucosa. AR were found in all samples from both neoplastic and non neoplastic surrounding mucosa, with no significant difference. Androgen receptor however exhibited an altered binding activity in cancer specimens. Cyproterone acetate did not displace DHT from AR while significant displacing activity was elicited by DHT, testosterone, as well as by lithocholic acid, but not by deoxycholic acid.
CONCLUSION: In cancerous large bowel mucosa, androgen receptors show altered binding characteristics. The selective binding of lithocholic acid to AR supports the hypothesis that diet-related endoluminal substances may play a role in cancer development model where molecular alterations such as DNA damage or mutation is the 1st event.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15206167

Source DB:  PubMed          Journal:  Panminerva Med        ISSN: 0031-0808            Impact factor:   5.197


  5 in total

Review 1.  Androgens and esophageal cancer: What do we know?

Authors:  Olga A Sukocheva; Bin Li; Steven L Due; Damian J Hussey; David I Watson
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

2.  Genetic variation in sex-steroid receptors and synthesizing enzymes and colorectal cancer risk in women.

Authors:  Jennifer Lin; Robert Y L Zee; Kuang-Yu Liu; Shumin M Zhang; I-Min Lee; JoAnn E Manson; Edward Giovannucci; Julie E Buring; Nancy R Cook
Journal:  Cancer Causes Control       Date:  2010-02-11       Impact factor: 2.506

3.  Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.

Authors:  Yong Zhang; Hao Liu; Li Li; Min Ai; Zheng Gong; Yong He; Yunlong Dong; Shuanglan Xu; Jun Wang; Bo Jin; Jianping Liu; Zhaowei Teng
Journal:  PLoS One       Date:  2017-08-03       Impact factor: 3.240

4.  Androgen receptor gene methylation related to colorectal cancer risk.

Authors:  Tingting Xia; Hongru Sun; Hao Huang; Haoran Bi; Rui Pu; Lei Zhang; Yuanyuan Zhang; Ying Liu; Jing Xu; Justina Ucheojor Onwuka; Yupeng Liu; Binbin Cui; Yashuang Zhao
Journal:  Endocr Connect       Date:  2019-07       Impact factor: 3.335

5.  Progesterone suppresses the progression of colonic carcinoma by increasing the activity of the GADD45α/JNK/c‑Jun signalling pathway.

Authors:  Yao-Lei Zhang; Xu-Dong Wen; Xin Guo; Shang-Qing Huang; Ting-Ting Wang; Pei-Ting Zhou; Wei Li; Long-Fu Zhou; Yong-He Hu
Journal:  Oncol Rep       Date:  2021-04-13       Impact factor: 3.906

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.